Compare Oruka Therapeutics Inc. Common Stock (ORKA) vs DENTSPLY SIRONA Inc (XRAY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Oruka Therapeutics Inc. Common Stock vs DENTSPLY SIRONA Inc — how do they compare? Oruka Therapeutics Inc. Common Stock trades at $75.2 (market cap $5.08B), while DENTSPLY SIRONA Inc trades at $8.54 (market cap $1.68B). The key difference: Oruka Therapeutics Inc. Common Stock is far larger — about 3× DENTSPLY SIRONA Inc's market cap, and DENTSPLY SIRONA Inc pays a 5.04% dividend while Oruka Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Oruka Therapeutics Inc. Common Stock for 0 Days and DENTSPLY SIRONA Inc for 72 Days on average.
| ORKA | XRAY | |
|---|---|---|
Market Cap | $5.08B | $1.68B |
Volume | 685,276 | 3,968,929 |
Sector | Health | Health |
52-Week High | $113.08 | $14.68 |
52-Week Low | $26.19 | $8.44 |
Typical Hold Time | 0 Days | 72 Days |
Enterprise Value | $4.21B | $3.76B |
Dividend Yield | — | 5.04% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
DENTSPLY SIRONA (XRAY) trades at $8.505, down 0.29% and near 52-week lows, with bearish technical signals and mixed fundamentals. The company reported Q2 2026 EPS of $0.52 beating estimates but faces declining revenue and negative margins. Recent news highlights institutional stake increases and ongoing restructuring efforts amid weak dental market conditions.
The stock presents a high-risk opportunity with analyst consensus at $12.50 (47% upside) but requires careful monitoring of margin recovery and sales stabilization. Key risks include persistent net losses, competitive pressures, and execution challenges in the turnaround plan.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Oruka Therapeutics Inc. Common Stock
Oruka Therapeutics, Inc. is a clinical-stage biotechnology company developing extended half-life monoclonal antibodies for plaque psoriasis, psoriatic arthritis, and related dermatologic conditions, with lead candidates ORKA-001 and ORKA-002 in clinical trials.
Read more on ORKA →About DENTSPLY SIRONA Inc
Dentsply Sirona Inc is a global manufacturer and distributor of dental supplies and equipment. The company's operating segments include Technologies & Equipment, which is responsible for the design, manufacture, sales, and distribution of products including dental implants, CAD/CAM systems, orthodontic clear aligner products, imaging systems, treatment centers, instruments, as well as certain healthcare device products, primarily catheters
Read more on XRAY →
